BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36655820)

  • 1. Remote, Computerised Cognitive Assessment for Breast Cancer- and Treatment-Related Cognitive Dysfunction: Psychometric Characteristics of the Cogsuite Neurocognitive Battery.
    Root JC; Gaynor AM; Ahsan A; Jung D; Schofield E; Ryan E; Li Y; Ahles TA
    Arch Clin Neuropsychol; 2023 Jul; 38(5):699-713. PubMed ID: 36655820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors.
    Gaynor AM; Ahsan A; Jung D; Schofield E; Li Y; Ryan E; Ahles TA; Root JC
    J Cancer Surviv; 2024 Apr; 18(2):466-478. PubMed ID: 35939254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer.
    Patel SK; Meier AM; Fernandez N; Lo TTY; Moore C; Delgado N
    Clin Neuropsychol; 2017 Nov; 31(8):1375-1386. PubMed ID: 28080264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study.
    McDeed AP; Van Dyk K; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Nakamura ZM; Rentscher KE; Saykin AJ; Small BJ; Root JC; Jim H; Patel SK; Mcdonald BC; Mandelblatt JS; Ahn J
    JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38556480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study.
    Van Dyk K; Ahn J; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Dilawari AA; Graham D; Jacobsen PB; Jim H; McDonald BC; Nakamura ZM; Patel SK; Rentscher KE; Saykin AJ; Small BJ; Mandelblatt JS; Root JC
    J Geriatr Oncol; 2022 Nov; 13(8):1132-1140. PubMed ID: 36030173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.
    Ferguson RJ; Sigmon ST; Pritchard AJ; LaBrie SL; Goetze RE; Fink CM; Garrett AM
    Cancer; 2016 Jun; 122(11):1782-91. PubMed ID: 27135464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of semantic memory in mild cognitive impairment: The psychometric properties of a novel semantic battery.
    Ohman A; Sheppard C; Monetta L; Taler V
    Appl Neuropsychol Adult; 2022; 29(4):492-498. PubMed ID: 32546014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers.
    Harrison JE; Barry H; Baune BT; Best MW; Bowie CR; Cha DS; Culpepper L; Fossati P; Greer TL; Harmer C; Klag E; Lam RW; Lee Y; Mansur RB; Wittchen HU; McIntyre RS
    Int J Methods Psychiatr Res; 2018 Sep; 27(3):e1736. PubMed ID: 30088298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
    O'Farrell E; Smith A; Collins B
    Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's Disease.
    Lea R; Benge JF; Adler CH; Beach TG; Belden CM; Zhang N; Shill HA; Driver-Dunckley E; Mehta SH; Atri A
    J Clin Exp Neuropsychol; 2021 Nov; 43(9):918-925. PubMed ID: 35138228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
    Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
    Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue.
    Betscher E; Guenter W; Langdon DW; Bonek R
    Neurol Neurochir Pol; 2021; 55(1):59-66. PubMed ID: 33047783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliable change in neuropsychological assessment of breast cancer survivors.
    Andreotti C; Root JC; Schagen SB; McDonald BC; Saykin AJ; Atkinson TM; Li Y; Ahles TA
    Psychooncology; 2016 Jan; 25(1):43-50. PubMed ID: 25808921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation and validation of a computerized neurocognitive battery in the Xhosa of South Africa.
    Scott JC; Moore TM; Stein DJ; Pretorius A; Zingela Z; Nagdee M; Ngqengelele L; Campbell M; Sibeko G; King MC; McClellan JM; Port AM; Jackson C; Ruparel K; Susser ES; Gur RC
    Neuropsychology; 2021 Sep; 35(6):581-594. PubMed ID: 34242045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
    Darwish H; Zeinoun P; Farran N; Ghusn H; Yamout B; Khoury SJ
    J Int Neuropsychol Soc; 2022 Jan; 28(1):94-103. PubMed ID: 33563350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient's assessment of own functioning inventory.
    Van Dyk K; Ganz PA; Ercoli L; Petersen L; Crespi CM
    Support Care Cancer; 2016 Dec; 24(12):4939-4949. PubMed ID: 27432402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of the NeuroCognitive Performance Test, a web-based neuropsychological assessment.
    Morrison GE; Simone CM; Ng NF; Hardy JL
    Front Psychol; 2015; 6():1652. PubMed ID: 26579035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada.
    Mariani M; Collins MWG
    Support Care Cancer; 2018 Nov; 26(11):3801-3809. PubMed ID: 29774475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.